Glutathione depletion resulting in selective mitochondrial complex I inhibition in dopaminergic cells is via an NO‐mediated pathway not involving peroxynitrite: implications for Parkinson's disease
Open Access
- 2 February 2005
- journal article
- research article
- Published by Wiley in Journal of Neurochemistry
- Vol. 92 (5) , 1091-1103
- https://doi.org/10.1111/j.1471-4159.2004.02929.x
Abstract
An early biochemical change in the Parkinsonian substantia nigra (SN) is reduction in total glutathione (GSH + GSSG) levels in affected dopaminergic neurons prior to depletion in mitochondrial complex I activity, dopamine loss, and cell death. We have demonstrated using dopaminergic PC12 cell lines genetically engineered to inducibly down‐regulate glutathione synthesis that total glutathione depletion in these cells results in selective complex I inhibition via a reversible thiol oxidation event. Here, we demonstrate that inhibition of complex I may occur either by direct nitric oxide (NO) but not peroxinitrite‐mediated inhibition of complex I or through H2O2‐mediated inhibition of the tricarboxylic acid (TCA) cycle enzyme α‐ketoglutarate dehydrogenase (KGDH) which supplies NADH as substrate to the complex; activity of both enzymes are reduced in PD. While glutathione depletion causes a reduction in spare KGDH enzymatic capacity, it produces a complete collapse of complex I reserves and significant effects on mitochondrial function. Our data suggest that NO is likely the primary agent involved in preferential complex I inhibition following acute glutathione depletion in dopaminergic cells. This may have major implications in terms of understanding mechanisms of dopamine cell death associated with PD especially as they relate to complex I inhibition.Keywords
This publication has 77 references indexed in Scilit:
- Direct Evidence of Nitric Oxide Presence within MitochondriaBiochemical and Biophysical Research Communications, 2000
- Catechol-O-methyltransferase genotype and susceptibility to Parkinson's disease in JapanJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1997
- What nitrates tyrosine? Is nitrotyrosine specific as a biomarker of peroxynitrite formation in vivo?FEBS Letters, 1997
- Alterations in the distribution of glutathione in the substantia nigra in Parkinson's diseaseJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1997
- The molecular mechanisms of the metabolism and transport of iron in normal and neoplastic cellsBiochimica et Biophysica Acta (BBA) - Reviews on Biomembranes, 1997
- Posttranslational Modification of Glyceraldehyde-3-phosphate Dehydrogenase by S-Nitrosylation and Subsequent NADH AttachmentJournal of Biological Chemistry, 1996
- An immunohistochemical study on α‐ketoglutarate dehydrogenase complex in Parkinson's diseaseAnnals of Neurology, 1994
- Mitochondrial Complex I Deficiency in Parkinson's DiseaseJournal of Neurochemistry, 1990
- Nitric oxide: A cytotoxic activated macrophage effector moleculeBiochemical and Biophysical Research Communications, 1988
- Idiopathic Parkinson's disease, progressive supranuclear palsy and glutathione metabolism in the substantia nigra of patientsNeuroscience Letters, 1986